Lilly's phase 2 retatrutide results show the investigational molecule achieved up to 17.5% mean weight reduction
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Effective disaster response and management is a collaborative work
Survey of Unmet Needs in chronic myeloid leukemia (CML SUN) data signal need for amplified patient voice during treatment discussions that balance quality of life (QoL), efficacy, and tolerability goals across all lines of therapy
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone
US formulations revenue increased by 11.6% YoY to Rs. 3,045 crore and Europe formulation revenue stood at Rs. 1,660 crore
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
India’s efforts are aimed at boosting health at the last mile
These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
Subscribe To Our Newsletter & Stay Updated